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Purpose: Corneal dystrophy of Bowman’s layer (CDB) belongs to a group of dystrophies associated with mutations in
the transforming growth factor-beta-induced (TGFBI) gene. CDB is further divided into a geographic variant (CDB1/Reis
Bücklers, RBCD), and a honeycomb variant (CDB2/Thiel Behnke, TBCD). We undertook mutational analysis of TGFBI
in a family with an unusual CDB variant and describe a novel phenotype-genotype association.
Methods: Individuals from a pedigree with CDB underwent extensive phenotyping, including laser scanning in vivo
confocal  microscopy,  and  histological  examination  of  four  corneal  buttons  obtained  at  penetrating  keratoplasty.
Transmission electron microscopy of an excised allograft cornea from one affected individual was also performed.
Following informed consent, DNA samples were collected. Polymerase chain reaction (PCR) and sequencing of all coding
exons of TGFBI was performed. Family members were recruited with subsequent phenotyping and genotyping, and
paternity testing.
Results: Clinical examination and other phenotypic information confirmed a diagnosis of CDB, with various features
either more suggestive of CDB1 or of CDB2. A mutation in exon 14, H626P, segregated with the disease in this pedigree.
This mutation was confirmed with NlaIII restriction enzyme digest, and was not seen in 100 control chromosomes.
Conclusions: Within this pedigree, CDB segregates with an H626P mutation, which is previously described occurring in
lattice corneal dystrophy. The majority of mutations in TGFBI previously described segregating with CDB1 and CDB2
are R124L and R555Q, respectively. Although a Bowman’s layer dystrophy, the phenotype in this pedigree does not
closely conform to the classical diagnostic criteria for either CDB1 or CDB2, and therefore represents a novel phenotype-
genotype correlation.
Reis-Bücklers corneal dystrophy (RBCD/CDB1, OMIM
608470) was first described by Reis in 1917 as an annular
dystrophy (dystrophia anularis) [1]. Bücklers re-examined the
same pedigree in 1949 and showed that the dystrophy was
present  in  four  consecutive  generations  [2],  and  affected
members consistently presented with painful corneal erosions
in childhood, with geographic opacities seen at the level of
Bowman’s  layer.  Thiel  and  Behnke  described  a  similar
corneal  dystrophy  in  1967  that  presented  with  recurrent
erosions,  moderately  reduced  vision,  autosomal  dominant
inheritance, and honeycomb shaped opacities at the level of
Bowman’s layer (TBCD/CDB2, OMIM 602082) [3].
Since the report of Thiel and Behnke, descriptions in the
literature  have  varied  in  nomenclature  and  classification,
rendering differentiation between autosomal dominant CDB1
and  CDB2  difficult  [4-7].  In  a  comprehensive  review
preceding genetic characterization, Küchle et al. [5] proposed
that these dystrophies are indeed two distinct entities that
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differ markedly in their appearance at the slit-lamp, associated
degree of visual loss, histopathological findings, transmission
electron microscopy (TEM) features, and prognosis following
corneal  transplantation.  Using  Kuchle’s  classification  -
clinically,  CDB1  is  described  as  exhibiting  confluent
geographic  opacities  at  the  level  of  Bowman’s  layer  and
histopathology  demonstrates  band  shaped  granular,
subepithelial deposits which stain intensely red with Masson
trichrome. TEM reveals the presence of “rod shaped bodies”
[5]. In contrast CDB2 has honeycomb shaped opacities, a
subepithelial  fibrocellular  layer  interposed  between  the
epithelium  and  stroma,  stains  less  strongly  with  Masson
trichrome and has “curly collagen” fibers present on TEM
[5]. While visual loss with CDB1 is described as early and
marked [1,2,5], with CDB2 it is later and moderate [3,5]. The
recurrence of the dystrophy after corneal transplantation is
noted to be early with CDB1 and much later with CDB2 [5].
Following  linkage  of  CDB1  and  other  corneal
dystrophies (Granular, Avellino, and Lattice) to 5q31 [8,9],
Munier  et  al.  [10]  reported  mutations  in  the  TGFBI
(transforming  growth  factor  -beta-induced)  gene  (OMIM
601692)  correlating  the  R555Q  mutation  with  CDB1.
However,  later,  clinical,  molecular  and  ultrastructural
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1503findings  have  demonstrated  that  it  is  actually  CDB2  that
correlates with the mutation R555Q and CDB1 to the mutation
R124L [11-14].
TGFBI, initially called BIGH3 [15], encodes for a 683
amino  acid  protein  product,  with  several  nomenclatures
including “keratoepithelin” and the now preferred “TGFBI
associated  protein,”  TGFBIp.  This  extracellular  matrix
protein is expressed in many tissues including the corneal
epithelium  [16],  and  contains  four  regions  of  internal
homology known as Fasciclin-like (Fas) domains. The protein
has  high  sequence  homology  to  fasciclin1,  an  insect  cell
adhesion  molecule,  and  is  thought  to  play  a  role  in  cell
adhesion [17]. The majority of mutations in TGFBI reported
to date have been located either within the codon encoding for
amino acid R124, or at the boundary of, or within the Fas
domain  4  [4,12],  although  a  few  mutations  outside  these
regions are also reported [18-22]. Immunohistological studies
have shown TGFBIp to be present in the abnormal corneal
deposits seen in certain corneal dystrophies [23], as well as in
secondary amyloidosis in corneal disease unrelated to TGFBI
mutations [24].
We report a four-generation family with an autosomal
dominant dystrophy that was initially diagnosed as CDB1 on
the  basis  of  clinical  appearance  and  clinical  course.
Comprehensive  characterization  of  the  disease  included
expert  clinical  assessment,  in  vivo  confocal  microscopy,
histology  on  four  primary  corneal  buttons  and  a  corneal
allograft  with  disease  recurrence,  immunohistochemical
staining, TEM, and mutational analysis of TGFBI. The results
of these investigations suggest a novel genotype-phenotype
correlation.  Comparison  of  these  data  with  an  extensive
review of the literature supports our view that this reported
dystrophy, although exhibiting some features of both CDB1
and CDB2, does not meet the diagnostic classification for
either, thereby adding to the complexity of the pathogenesis
of the TGFBI corneal dystrophies.
METHODS
Patient recruitment: Individuals from a single four-generation
pedigree of Caucasian ethnicity (Figure 1) with autosomal
dominant  CDB  were  recruited  from  the  Department  of
Ophthalmology,  Auckland,  New  Zealand  District  Health
Board  and  then  assessed  at  the  University  of  Auckland
Ophthalmology Clinic. The study design adhered to the tenets
of the Declaration of Helsinki, with Institutional Research
Ethics Board approval. After providing verbal and written
explanations of the purpose and possible consequences of the
study participants gave their informed consent.
Clinical  examination:  All  subjects  underwent  extensive
clinical  examination  by  a  single,  experienced,  examiner
including Snellen visual acuity, slit-lamp biomicroscopy, and
anterior segment photography. Three affected individuals (II:
1, III:1, and III:5) were also studied by laser scanning in vivo
confocal  microscopy  (Heidelberg  Retina  Tomograph  II,
Rostock Corneal Module (RCM); Heidelberg Engineering
GmbH, Heidelberg, Germany).
Histopathology and transmission electron microscopy: The
corneal tissue from four affected individuals - four primary
corneal buttons (II:1, III:1, III:2, and III:5) and one allograft
(II:1)  -  was  examined  histopathologically  following
penetrating  keratoplasty  (PKP)  for  reduced  visual  acuity.
Tissue for light microscopy was fixed in 10% formalin in 0.1
M phosphate buffer then stained with hematoxylin and eosin
(H&E), Congo red, periodic acid Schiff (PAS), alcian blue,
and Masson’s trichrome. One of these patients had undergone
repeat keratoplasty for recurrence of the dystrophy within the
corneal graft and the tissue recovered following this was also
studied by TEM. This tissue was fixed in Karnovsky’s fixative
then washed in 0.1 M phosphate buffer. The tissue was post
fixed in 0.5% osmium tetroxide in 0.1 M phosphate buffer for
2 h before being dehydrated through a graded ethanol series
and embedded in procure 812 resin. Resin blocks were cut into
sections and placed on copper grids for transmission electron
microscopy.
Immunofluorescence: One quarter of the tissue sample (II:1)
was fixed in 2.5% paraformaldehyde for 1 h, then washed and
mounted in TissueTek® OCT medium. Sections (20 μm) were
cut  in  an  antero-posterior  direction  and  collected  onto
Superfrost Plus slides (Menzel Glaser, Germany). Standard
immunofluorescence  labeling  techniques  were  used  to
incubate the sections with affinity-purified rabbit anti-TGFBI
antibody  [25]  (Antibody  courtesy  of  Dr  Andrew  Huang,
University of Minnesota, Minneapolis, MN) overnight at 4 °C
and a CY3 conjugated secondary antibody for 2 h. Sections
were counterstained with DAPI, mounted in Citifluor medium
(Citifluor Ltd, UK) and coverslip applied. Slides were viewed
using a Leica DMRA microscope and images captured using
a  Nikon  Digital  Sight  DS-U1  camera  system  and  NIS
Figure  1.  A  four-generation  pedigree  illustrating  affected  and
unaffected individuals. Either "+" or "–" denotes presence or absence
of mutant allele, and denotes all the individuals examined. The three
younger members of the pedigree (triplets) with the mutant allele
were age 3 years at time of last examination, and appeared clinically
unaffected.  CDB=Bowman’s  layer  corneal  dystrophy,
PPCD=posterior polymorphous corneal dystrophy.
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Adobe Photoshop®.
Mutational  analysis:  Biologic  samples  (peripheral  blood,
buccal swab, saliva) were collected from six members of the
pedigree  affected  with  CDB,  one  member  affected  with
posterior polymorphous dystrophy (PPCD), three unaffected
members, and five individuals of unknown affected status due
to their age. Leukocyte DNA extraction was performed using
the salt extraction method [26]. Buccal and saliva DNA were
extracted  following  manufacturers  guidelines  (Purgene®
DNA purification kit; Gentra Systems, Minneapolis, MN and
Oragene; DNA Genotek, Ottawa, ON, Canada, respectively).
PCR amplification of all the coding exons of TGFBI (exons
1–17) was undertaken using previously described primers and
conditions  [12].  Following  column  purification  using  a
HighPure  PCR  purification  kit  (Roche  Diagnostic,
Mannheim, Germany), the product was sequenced directly
according  to  protocols  accompanying  the  ABI  BigDye
terminator kit v3.1. Bidirectional sequencing of amplicons
was  undertaken  on  an  ABI  3100  prism  genetic  analyzer
(Applied Biosystems Inc., Foster City, CA), to collect and
analyze  the  sequence  data.  Nucleotide  sequences  were
compared with the published TGFBI cDNA (cDNA) sequence
(GenBank NM_000358).
The exon 14 sequence variant was confirmed with NlaIII
restriction enzyme digest using 9 μl PCR product, 0.2ul NlaIII
(New England BioLabs, Beverly, MA), 1.2 μl NEBuffer 4 (50
mmol  potassium  acetate,  20  mM  Tris  acetate,  10  mmol
magnesium acetate, 1 mmol DDT, pH7.9 at 25 °C), 0.12 μl
BSA  (100X),  and  1.48  μl  H20  (total  12  μl),  which  was
incubated overnight at 37 °C.
Paternity  testing:  Paternity  testing  was  undertaken  on
individuals I:1, and II:1 using 12 heterogeneous polymorphic
markers throughout the genome with known population allele
frequencies,  which  were  genotyped  on  the  ABI  prism.
Parental index was calculated using Brenners formula. Fifty
unaffected control individuals (100 control chromosomes) of
matched ethnicity also underwent NlaIII restriction enzyme
digestion of the exon 14 amplicon.
RESULTS
Clinical presentation: Six members of the pedigree affected
with CDB, one member affected with PPCD, three unaffected
members, and five members of unknown affected status due
to their age
were  identified  and  examined.  Affected  members  were
diagnosed at a mean age of 10.3±1.5 (mean±SD) years with
symptoms  of  painful  recurrent  corneal  erosions.  A  rapid,
progressive reduction in visual acuity was reported during
their teenage years and at the time of review by the authors
best corrected visual acuity (BCVA) varied significantly in
affected eyes (6/18−2-6/60; Table 1).
Slit-lamp biomicroscopy typically showed an irregular
corneal surface with discrete, gray-white opacities of various
morphologies  in  the  sub-epithelial  area  that  projected
anteriorly from the level of Bowman’s layer into the overlying
epithelium. The overlying epithelium was intact. With longer
duration  from  diagnosis  these  opacities  were  noted  in
increasing  association  with  marked  corneal  scarring,
neovascularization, and calcification. No stromal lattice lines
were observed. Representative clinical photographs of the left
cornea of an affected family member are shown in Figure 2.
Corneal sensation was diminished on qualitative assessment
in all affected eyes.
In vivo laser scanning confocal microscopy (IVCM) was
performed on three of the affected subjects. Within the basal
epithelial layer of the proband’s right eye, focal deposition of
homogeneous reflective materials with rounded edges and
hyporeflective borders was observed (Figure 3A). Extensive
hyper-reflectivity extending throughout the full thickness of
the stroma consistent with scarring, neovascularisation and
ghost  vessels  was  also  noted  (Figure  3B,C).  This  hyper-
reflectivity in combination with the absence of focal, highly
reflective,  small  granular  materials  at  the  same  level  has
recently been described as a further feature of CDB2, thereby
differentiating it from CDB1 [11]. Ghost vessels have well
defined margins and have hyporeflective borders (as shown
in Figure 3B). Also, blood vessels are clearly visible clinically
(Figure 3C) and correlate with the appearance and location of
structures observed in Figure 3B. Amyloid deposits appear as
hyperreflective, linear, and branching structures with varying
reflectivity and poorly demarcated margins. Such structures
were not present on any IVCM images from the subject.
In the right eye of subject II:1, which had undergone an
allograft four years earlier, diffuse, homogeneous, reflectivity
was noted at the level of Bowman’s layer (Figure 3D) which
correlated with the clinical appearance of recurrence of the
dystrophy on slit-lamp biomicroscopy (Figure 3E).
Four  affected  individuals  underwent  PKP  (six  eyes),
while  four  underwent  excimer  laser  phototherapeutic
keratectomy  (PTK;  six  eyes)  that  produced  significant
improvements in both their symptoms and visual acuity. One
Figure  2.  Representative  slit-lamp  biomicroscopy  photographs
illustrating corneal phenotype in an affected individual.  A: 10X
magnification diffuse illumination and B: 16X magnification broad
slit lamp slit illumination of the left cornea of subject III:5.
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1505Figure  3.  In  vivo  confocal  microscopy  images  of  representative
affected  family  members.  The  right  eye  (virgin  cornea)  of  the
proband (frame size 400 µm x 400 µm) at the level of (A) basal
epithelial  layer  illustrating  focal  deposition  of  homogeneous,
reflective materials with rounded edges, and hyporeflective borders
and (B) posterior stroma showing extensive scarring with arrow
indicating  “ghost”  blood  vessels.  C:  Corresponding  slit-lamp
biomicroscopy photograph illustrating dense scarring. D: In vivo
confocal microscopy of the allograft in the right eye of subject II:1
at the level of Bowman’s layer which has been completely replaced
by diffuse, homogeneous, reflective material (frame size 400 µm x
400 µm). E: Corresponding slit-lamp biomicroscopy photograph
illustrating recurrence of the dystrophy within the peripheral right
corneal  graft  of  subject  II:1,  4  years  following  penetrating
keratoplasty.
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1506subject (II:1) underwent repeat PKP for recurrence of the
dystrophy 18 years after the initial corneal graft in the left eye.
The clinical features of the pedigree are summarized in Table
1.
Histopathologic analysis: All four corneal buttons from the
primary grafts demonstrated subepithelial deposits of hyaline
material  of  variable  thickness  that  did  not  stain  red  with
Masson trichrome and was not present within the anterior
stroma  per  se.  Bowman’s  layer  was  absent/replaced  over
much of the excised cornea with poor basal lamina formation
noted,  and  areas  of  poor  adhesion  of  the  basal  cells  to
Bowman’s layer (where present) and the hyaline material
where Bowman’s layer was absent. The deposits of hyaline
material were PAS, Alcian blue, and Congo red negative. In
two of the corneas there were extensive secondary changes of
neovascularization, calcification, and scarring. There were no
other deposits seen within the stroma, and specifically no
amyloid staining. Descemet’s membrane and the endothelium
were normal in all corneas.
Light  microscopy  of  the  corneal  allograft  from  II:1,
showed similar histopathological features. TEM examination
of this corneal specimen showed an irregular epithelium with
poor  attachment  to  the  underlying  substratum  (Figure  4).
Although this could be an artifact of tissue processing, this
was consistent with the clinical findings of a loose superficial
layer that could easily be peeled off underlying corneal tissue.
On TEM a band of subepithelial material largely obliterated
Bowman’s layer. This appeared to be composed of irregular
aggregates of curved fibrils intermingled with collagen fibers.
No  rod  shaped  bodies  were  identified.
Immunohistofluorescence confirmed the presence of TGFBIp
within this subepithelial deposit (Figure 5).
Molecular  genetic  analysis:  Bidirectional  DNA  sequence
analysis revealed a missense transversion A→C at nucleotide
1877 in exon 14 (c.1877A>C), resulting in a substitution of
Figure 4. Transmission electron microscopy images of the corneal
allograft from subject II:1. A: Low magnification photomicrograph
showing basal epithelial cells (Ep) overlying a band of deposit (De),
at higher magnification in B. The insert in B is shown in higher
magnification in C, demonstrating the degenerating basal epithelial
cell (Dc) above the dotted line, and below the subepithelial deposit,
consisting of irregular aggregates of fibrils (Cf) as demonstrated with
arrows. The large arrowhead shows a degenerating adhesion body.
histidine  by  proline  (CAT→CCT,  p.H626P;  Figure  6).  In
addition the proband was heterozygous for one previously
described SNP in exon 6, (c.651C>G, L217L). Due to the
removal  of  an  NlaIII  restriction  site,  the  presence  of  the
mutation c.1877A>C could be confirmed by electrophoresis
after  enzymatic  digest  of  exon  14  in  affected  but  not
unaffected  family  members,  or  unaffected,  unrelated,
individuals. The mutation was confirmed by sequencing after
enzyme digestion in all affected individuals, co-segregated
with  disease  in  the  clinically  affected  individuals  in  this
pedigree, and was also present in three younger members of
the pedigree (IV:3, IV:4, and IV:5). As these triplets were
three years of age at the time of the examination, affected
status could not be determined, therefore segregation with
these individuals, and with individual IV:1 (age 2) cannot be
commented on. The cousin with PPCD (III:8) also did not
carry  the  c.1877A>C  sequence  change.  H626P  was  not
present in 100 control chromosomes.
Figure  5.  Immunohistochemical  staining  of  a  corneal  allograft
specimen  (II.1).  The  presence  of  TGFBI  associated  protein  is
demonstrated in the sub epithelial deposit (red). Corneal epithelial
nuclei are stained with DAPI (blue). The right hand image shows the
corresponding phase contrast light microscopy image. Magnification
40X.
Figure  6.  Electropherogram  of  TGFBI  exon  14  in  an  affected
individual. This revealed a missense transversion A→C at nucleotide
1877,  resulting  in  a  substitution  of  histidine  by  proline
(CAT→CCT, H626P).
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1507A  parental  index  of  >99.5%  is  highly  suggestive  of
paternity  for  individuals  I.1  and  II.1  (data  not  shown).
Maternity  testing  was  unable  to  be  performed  as  I:2  is
deceased, but review of her eye notes before her death record
no evidence of corneal abnormality at the age of 78 years.
DISCUSSION
Phenotypically this pedigree had some features that overlap
with both CDB1 and CDB2. Features typically associated
with CDB1 include marked visual loss (BCVA range pre-
treatment 6/18−2-6/60), a young age at presentation (10.3±1.5
years, mean± SD) and early extensive recurrence observed
following PKP in one individual [5]. Slit-lamp biomicroscopy
also revealed confluent opacities that appeared geographic in
shape  as  opposed  to  the  honeycomb  shaped  opacities  of
CDB2.  However,  histopathology  revealed  that  the
subepithelial deposits did not stain red with Masson trichrome
- a feature more characteristic of CDB2, often reported as
minimal or questionable staining [5,14,27]. In vivo confocal
microscopy images were consistent with reported findings in
CDB2  [11].  Of  the  5  youngest  members  of  the  pedigree
examined  and  tested,  three  carried  the  mutation  but  were
apparently  clinically  unaffected  on  slit  lamp  examination.
However, they were at an age (3 years) much younger than
the mean onset of disease symptoms/signs (10.3±1.5) in this
pedigree.
Unfortunately tissue samples were not available on all
subjects treated for corneal opacification, decreased vision
and recurrent erosions. Although subjects with severe scarring
and  vascularization  (and  those  treated  before  1990)  were
treated by PKP, in selected members of the pedigree with the
primarily  superficial  corneal  lesions  seen  early  in  this
dystrophy,  excimer  laser  phototherapeutic  keratectomy
(PTK) was used successfully [28]. Having been shown to be
a safe and effective alternative to re-grafting it has recently
been  used  by  the  authors  to  treat  the  recurrence  of  the
dystrophy in subject II:1 OD, with a promising early post
operative result [29].
On light microscopy, a variable thick band of hyaline
avascular connective tissue and/or fibrocellular tissue was
identified beneath the corneal epithelium which did not stain
red with Masson’s trichrome stain. (Figure 7) In the allograft
specimen, the characteristic rod-shaped bodies observed in
CDB1  were  clearly  not  identified  on  TEM,  and  high
magnification TEM demonstrated the subepithelial deposit
immediately underlying degenerating basal epithelial cells.
This  deposit  appears  to  consist  of  cell  debris  with  some
irregular  aggregates,  and  scattered  fibrils.  These
histopathological  observations  are  not  classically
characteristic of either CDB1 or CDB2, although perhaps the
presence of fibrils is more in keeping with a CDB2 variant
[5,14,19]. Immunofluorescence demonstrated TGFBIp within
the subepithelial deposit, which is consistent with the findings
of Streeten et al. [27], who showed strong specificity of the
stain  to  the  curly  fibers.  However  TGFBIp  has  been
demonstrated in secondary corneal amyloidosis (confirmed
with Congo red) in non-TGFBI-associated disease [24]. No
Congo red staining was observed in any of our 4 corneal
specimens, therefore this subepithelial band is unlikely to
represent  an  amyloid  deposit,  however,  the  presence  of
TGFBIp  is  apparently  not  sufficient  to  differentiate  a
dystrophic deposit from scar tissue [24].
The novel association of the mutation H626P with this
atypical CDB phenotype provides further evidence of the
complexities of the classification and nomenclature of the
TGFBI  corneal  dystrophies.  This  genotype-phenotype
correlation is unique from two perspectives: First -historically
CDB  has  predominantly  been  associated  with  2  different
distinct  mutations;  R124L  with  CDB1,  and  R555Q  with
CDB2 [13]. Second, the H626P mutation has been reported
with  a  significantly  different  phenotype  -  late  onset,
asymmetric, lattice, dystrophy, (variant LCD, classified by the
authors as CDLI/IIIA) [12], characterized by a dense haze
associated with lattice lines, demonstrating multiple fusiform
amyloid deposits in the stroma of an allograft corneal button.
Recently the H626P change was shown to segregate with a
superficial  dystrophy  that  also  showed  the  presence  of
amyloid [30]. A further mutation at this same base pair c.
1877A>G resulting in H626R has also been shown to co-
segregate  with  a  late  onset,  asymmetric,  form  of  lattice
dystrophy (with previous numbering c.1924) [12,19,31-34].
One family had disease onset at 27 years of age, no recurrent
erosions, and PKP necessary in the fifth decade [33]. H626R
is postulated as being responsible for up to 75% of LCD seen
in  a  Vietnamese  population  [32],  termed  LCDIIIB,  and
distinctive in that it has a later age of onset, asymmetry is
common, and the lattice lines are thicker and more rope-like.
Recently this mutation is described in a family with granular
corneal dystrophy (GCD) [35].
In  a  recent  paper  the  phenotype  associated  with  the
R124L  mutation  was  well  characterized,  but  as  a  corneal
biopsy in the proband failed to distinguish between CDB1 and
CDB2, the authors expound the virtues of genetic testing to
determine  the  diagnosis  [36].  These  genotype-phenotype
correlations (CDB1–R124L and CDBII–R55Q) have been
confirmed  numerous  times  with  more  detailed  clinical
characterization [13,14,36-38], and a suggested nomenclature
for these dystrophies is “Classic” CDB [4].
In contrast CDB occurring with mutations other than the
124  or  555  mutations  can  be  termed  “Atypical”  CDB;
however histology is not recorded in these cases. Rozzo et al.
[39] described F540Δ in CDB1, but reclassified the phenotype
as  late-onset  lattice  IIIa  (CDL3A).  Two  pedigrees  are
described with G623D [40,41], one of which was CDB1 with
apparent non-penetrance [40], and the other had deposits in
Bowman’s  layer,  anterior  stromal  lattice  lines,  with
symptomatic onset in the fourth decade [41].
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1508Figure 7. Representative light microscopy images of corneal buttons obtained at penetrating keratoplasty from affected family members. An
irregular epithelium is demonstrated with a variable thick band of hyaline avascular connective tissue and/or fibrocellular tissue below;
Bowman’s layer is largely obliterated. This material did not stain red with Masson’s trichrome stain. (A-H: Individual III:1); A: AB-10X,
B: PAS-10X, C: MTC-10X, D: CR-10X, E: AB-40X, F: PAS-40X, G: MTC-40X, H: CR-40X. (I-L: Individual II:1), I: HE-5X, J: PAS-40X,
K: HE-40X, L: CR-10X. (M-P: Individual III:2), M: HE-40X, N: PAS-40X, O: MTC-40X, P: CR-40X, and (Q-S: Individual III:5), Q:
HE-40X, R: PAS-40X, S: MTC-40X. Abbreviations used in the legend are: AB=Alcian Blue, PAS=periodic acid Schiff, MTC=Massons
trichrome, CR=Congo Red, and HE=hematoxylin and eosin.
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1509Paternity  testing  is  highly  suggestive  of  a  de  novo
mutation in TGFBI in II.1, by confirming the paternity of his
unaffected father, however maternity could not be confirmed
as  his  reportedly  unaffected  mother  had  died.  Further
possibilities which have not been investigated further include
parental germ line mosaicism, or non-penetrance from the
reportedly  unaffected  mother,  although  none  of  her  other
relatives were examined. Certainly de novo mutations have
been documented in TGFBI-associated disease, as well as
germ-line mosaicism [36,42,43]. It would appear that TGFBI
does  have  some  mutational  “hot-spots,”  where  identical
random mutations occur at an increased frequency at the same
site of a gene. Korvatska et al. [44,45] demonstrated different
haplotypes segregating with R124L in Japanese families, and
in  different  ethnicities.  They  suggested  that  mutations  at
codons  124  and  555  in  particular  represent  multiple
independent occurrences.
With the addition of this report, significant phenotypic
variability has now been demonstrated with the histidine at
position 626, segregating with CDB, GCD, and LCD IIIB
phenotypes. Likewise mutations within close proximity of the
626  residue  also  appear  to  show  phenotypic  variability.
Previous modeling of the structure of TGFBIp demonstrates
that His626 makes a crucial stabilizing hydrogen bond within
the Fas4 domain [17]. This hydrogen link would be abolished
by replacement of a proline, and therefore is likely to severely
destabilize  the  domain  [17].  So  why  is  there  such  broad
phenotypic  variability  seen  in  exon  14  mutations,  and  of
specific relevance here, to mutations involving the His 626?
Clout et al. [17]. also modeled His626Arg, which as well as
abolishing the hydrogen bond, is likely to make the protein
very  unlikely  to  fold  because  of  steric  hindrance  by  the
arginine residue
Although Fas4 domain mutations are thought to result in
misfolding of the protein, a major role of the Fas domain is to
mediate cell adhesion. TGFBIp also polymerizes to form a
fibrillar structure and strongly interacts with type I collagen,
laminin, and fibronectin [46]. It is unclear how the H626P
change results in the subepithelial deposit observed with poor
adherence to underlying tissues in this family, however one
possibility is the accumulation of mutant misfolded protein is
somehow deleterious to the cell, and a further theory is that
the mutant TGFBIp cannot participate adequately in its usual
binding functions, including polymerization to self and/or to
other tissues [17,46,47]. There does however appear to be a
corneal specific factor which influences this process, as other
epithelial tissues in the body from individuals with a mutation,
do not appear to manifest with TGFBIp deposits [47].
Other modifying factors could include co-existent SNPs,
although  there  is  no  prior  evidence  that  the  L217L  SNP
present in exon 6 of the proband has any functional role.
Interestingly, within this pedigree, slit-lamp biomicroscopy of
the proband’s cousin (III:8) clinically revealed PPCD. He did
not carry the mutation H626P, which could suggest that a
mutation  in  a  second  gene  may  be  responsible  for  his
phenotype, and perhaps even modify the expression of the
H626P mutation in this family.
The association of this pedigree with the phenotype CDB
and the mutation H626P is in keeping with the majority of the
published TGFBI mutations occurring either at Arg124 or
within the Fas4 domain, and the absence of this mutation in
our  100  control  chromosomes  and  in  previous  controls
suggests it is pathogenic rather than polymorphic. This novel
genotype-phenotype  correlation  challenges  our  current
knowledge  of  the  “phenotypic  specificity”  that  CDB1
segregates with the R124L genotype, and CDB2 with R555Q.
Likewise mutations at the 626 residue segregate with non-
lattice  phenotypes.  To  explain  the  marked  difference  in
phenotype between this pedigree and those described with
H626 mutations, it is possible that a modifying genetic or
environmental mechanism may be involved, the nature of
which  is  unknown.  Certainly  further  investigation  is
warranted on the nature of the deposits and the protein’s
properties. This H626P CDB phenotype does not fit neatly
into either CDB1 or CDB2 categories, and demonstrates the
striking  phenotypic  variability  observed  with  TGFBI
mutations. This study and recent molecular evidence therefore
highlights  the  ongoing  complexity  of  the  pathogenesis  of
TGFBI associated corneal dystrophies, and emphasizes the
need  to  review  the  current  nomenclature  used  to  define
TGFBI-associated dystrophies of Bowman’s layer.
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